Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

New Developments in the Control of Autophagy by Natural Products in Cervical Cancer

Hongzan Chen

Autophagy, a highly conserved cellular process, plays a crucial role in maintaining cellular homeostasis and promoting cell survival during stress conditions. Dysregulation of autophagy has been implicated in various diseases, including cancer. Cervical cancer, a prevalent malignancy among women, presents challenges in treatment due to its aggressive nature and resistance to conventional therapies. In recent years, there has been growing interest in exploring the potential of natural products as adjuvant therapies for cervical cancer, particularly those that can modulate autophagy. This review highlights the latest developments in understanding the interplay between autophagy and cervical cancer and discusses how natural products have emerged as promising candidates for autophagy modulation. We summarize the mechanisms by which selected natural products influence autophagy pathways in cervical cancer cells, including both autophagy inducers and inhibitors. Furthermore, we delve into the potential therapeutic implications of these findings and the challenges associated with translating preclinical results into clinical applications. By shedding light on the intricate relationship between autophagy, natural products, and cervical cancer, this review underscores the importance of further research in harnessing the therapeutic potential of autophagy modulation by natural products to enhance the efficacy of cervical cancer treatment.